Dietary Supplements Market (By Type: Vitamins, Minerals, Fibers & Specialty Carbohydrates, Omega Fatty Acids, Botanicals, Proteins & Amino Acids, and Others; By Form: Capsules, Tablets, Gummies, Soft gels, Liquids, Powders, and Others; By Application: General Health, Energy & Weight Management, Gastrointestinal Health, Diabetes, Bone & Joint Health, Immunity, Cardiac Health, Anti-cancer, and Others; By End User) - Global Industry Analysis, Size, Share, Growth, Forecast 2022 - 2030

The global dietary supplements market was estimated at US$ 152.95 billion in 2021 and expected to hit US$ 317.04 billion by 2030, with a CAGR of 8.4% during the estimate period 2022 to 2030.

Growth Factors:

Increasing consumer awareness toward personal health and wellbeing is expected to be a key driving factor for dietary supplements over the forecast period.  The working population around the globe is struggling to fulfill the dairy nutrient requirements owing to hectic work schedules and changing lifestyles. Increasing dependence on the supplements to fulfill the nutrient requirement owing to their high convenience is expected to drive the market over the forecast period.

The U.S emerged as a leading market for dietary supplements in the North American region owing to the higher spending capacity of the consumers. Increasing spending on healthcare products, the rising geriatric population, rising interest in preventive healthcare, and growing interest in attaining wellness through diet are expected to augment market growth over the forecast period. A growing number of fitness centers, health clubs, and gymnasiums coupled with growing awareness about fitness among the youngsters is expected to increase the demand for energy and weight management. Increasing acceptance of sports as a career is expected to increase the demand for sports nutrition which in turn benefits the market for dietary supplements.

Research and development are the key success factor for dietary supplements which requires heavy investments. Also, stringent regulations regarding the health benefits claim and labeling of the products are expected to create challenges for the dietary supplements over the forecast period. The unprecedented outbreak of the COVID-19 pandemic has largely affected North America and European countries such as the U.S, Italy, Spain, the U.K, France, and Germany. The dietary supplement industry is largely concentrated in these regions which in turn benefitted from the situation as the market witnessed a surge in demand for immunity-boosting supplements.

Report Scope of the Dietary Supplements Market

Report Coverage

Details

Market Size

US$ xx Billion by 2030

Growth Rate

CAGR of xx% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Product, Source, Application, End-user and Region,

Companies Mentioned

 STEMCELL Technologies, Inc., Astellas Pharma, Inc., Cellular Engineering Technologies, Inc., BioTime, Inc., Takara Bio, Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics, Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., and Caladrius Biosciences, Inc.

 

Ingredient Insights

Vitamin as an ingredient dominated the dietary supplement market and accounted for more than 30.8% of the revenue share in 2021, owing to high demand from working professionals and sports athletes for energy and weight management. The users consume multivitamins through tablets, powder, and liquid owing to the higher convenience index in terms of usage. The botanical ingredient was the second largest sub-segment and is expected to witness a CAGR of 9.2% over the forecast period. Increasing adoption of a vegan diet around the globe owing to growing environmental concerns is expected to boost the demand for the botanical ingredient over the forecast period.

 

The proteins and amino acids segment is expected to witness the highest CAGR of 13.4% over the forecast period. Increasing demand for the protein supplements like whey powders and amino acid products like creatine, tyrosine, citrulline, and proline from the consumers owing to the increasing awareness on health and diet is expected to drive the market for dietary supplements over the forecast period. Energy and weight management product manufacturers are recently focusing more on incorporating nutraceutical ingredients to enhance the nutritional value of the products. It has increased the demand for the fibers and specialty carbohydrates that are indigestible by humans but help to reduce cholesterol levels, weight management, and control blood sugar level.

Form Insights

The tablets segment led the dietary supplements market and accounted for 33.6% of the revenue share in 2021. The higher prevalence of multivitamin products in the form of tablets owing to easy dosage, low cost, higher shelf life, and higher convenience is expected to positively impact the tablets segment over the forecast period. Growing importance for microencapsulation of the finished products to ensure the controlled release is expected to increase the demand for capsules from the health and wellness products manufacturers over the forecast period. However, their higher cost compared to tablets is expected to create challenges for the capsules over the forecast period.

A large number of brands including Optimum Nutrition, Quest Nutrition, NOW Foods, and MusclePharm are involved in the manufacturing of powders of protein, omega-3, minerals, and vitamin blends. Increasing demand for supplements in powder form from bodybuilders, elite athletes, and fitness enthusiasts is expected to boost the powdered dietary supplements over the forecast period. The liquid form is anticipated to witness the highest revenue CAGR of 12.1% over the forecast period. Liquid dietary supplements are liposomal products that can evenly disperse in the water allowing smooth consumption. Liquid form facilitates the easy formation of blends leading to higher usage in yogurt, smoothies, and other energy drinks.

Application Insights

The energy and weight management application segment led the market for dietary supplements and accounted for a revenue share of 30.6% in 2021. Other application of dietary supplements includes general health, bone & joint health, cardiac health, gastrointestinal health, anti-cancer, immunity, diabetes, lungs detox/cleanse, and others. Dietary supplements are primarily used to fulfill nutritional deficiencies in humans. Increasing awareness among the consumers regarding personal health and wellness is expected to drive the demand for dietary supplements including protein and amino acids, minerals, vitamins, and omega fatty acids over the forecast period.

Increasing awareness regarding gut health owing to the increasing prevalence of irritable bowel syndrome, constipation, acid reflux, and indigestion around the globe is expected to drive the demand for fibers and specialty carbohydrates from the gastrointestinal health application over the forecast period. Revenue from immunity application is anticipated to witness a CAGR of 8.8% over the forecast period. The outbreak of the COVID-19 pandemic in the year 2020 has increased the demand for immunity booster products all over the globe. Immunity-boosting vitamins, minerals, and herbs witnessed a surge in demand in 2020 which is expected to continue till the vaccine reaches everyone which is expected to benefit the segment.

Type Insights

The OTC type segment dominated the market for dietary supplements and accounted for the largest revenue share of 75.7% in 2021 and is expected to lead over the forecast period. OTC sales of dietary supplements are expected to witness steady growth owing to rising consumer awareness regarding the health benefits of dietary supplements. Initiatives related to healthcare infrastructural development along with the introduction of favorable policies by most governments across the world are likely to impact the popularity and expansion of OTC dietary supplements. OTC dietary supplement industry is focusing on improving the functionality of these supplements through innovations in product formulation, which, in turn, is expected to offer potential growth prospects in the market.

The prescribed dietary supplements segment is expected to register a CAGR of 9.8% over the forecast period. Prescribed supplements are manufactured with strict standards similar to that of pharmaceutical drugs. These supplements provide minimalistic side effects along with proper labeling. Strict regulation by the governing bodies and limited awareness among the individuals related to labeling and health claims is expected to drive the sales of prescription-based dietary supplements. An increasing number of prescribed dietary supplements for individuals with nutritional deficiencies for the precise delivery of nutrients is expected to drive the sales through the prescribed type over the forecast period.

End-user Insights

The adult segment dominated the market and accounted for the largest revenue share of 46.6% in 2021. Changing lifestyles and hectic work schedules among working adults are leading to nutritional deficiencies which are expected to lead to increased consumption of dietary supplements by adults. The increasing prevalence of obesity, cardiovascular diseases, diabetes, and other related conditions among adults around the globe is expected to be the key factor driving the market. Increasing acceptance of sports as a professional career is expected to drive the demand for dietary supplements like protein, vitamins, amino acids, and others over the forecast period.

A growing number of geriatric populations in the regions like North America, Europe, and the Asia Pacific is expected to augment market growth over the forecast period. With the geriatric population being susceptible to several infections, the demand for immunity boosters from these end-users in the covid-19 pandemic is expected to grow at a higher rate. Growing awareness regarding the nutritional requirements for children and infants is expected to augment the demand for dietary supplements. The growing working population and increasing per capita income in the developing economies are expected to increase consumer spending on infant nutrition over the forecast period which is expected to drive the market.

Distribution Channel Insights

The offline segment dominated the market and accounted for the largest revenue share of 81.0% in 2021. The offline distribution channel operates in brick and mortar model or direct-to-consumer model. Offline subcategories include supermarket/hypermarkets, pharmacies, specialty stores, practitioners, and other direct-to-customer channels for offering dietary supplements. Supermarkets/hypermarkets contribute significantly to the sales of dietary supplements in Europe and North America owing to higher prevalence. In the offline segment, the supermarket and hypermarket segment accounted for 33.9% of the overall sales of dietary supplements in 2021. According to a report published by Food Industry Asia in 2020, hypermarkets and supermarkets in Asia Pacific are likely to witness significant growth, with Vietnam, India, and the Philippines expected to grow at the highest CAGRs over the forecast period.  

The sales of dietary supplements through online distribution channels are expected to witness the highest growth in the coming years. Increased number of internet users, ease of access to a number of brands, fast-paced lifestyle of the masses, 24/7 availability of products, the convenience of shopping, and a wide range of products offered are factors driving the sales of dietary supplements through online distribution channels in the country. The sales of dietary supplements through online distribution channels are expected to witness the highest growth in the coming years.

Regional Insights

North America dominated the market for dietary supplements and accounted for the largest revenue share of 34.8% in 2021. It is projected to witness a CAGR of 5.6% over the forecast period on account of the growing use of products with high nutritional value and low calory content. Furthermore, increasing awareness about the consumption of supplement products in Mexico on account of new product launches is expected to drive the demand for dietary supplements over the forecast period. In Asia Pacific, the market is expected to witness higher revenue growth over the forecast period.

The region is expected to be the largest market for dietary supplements by 2030 owing to the growing consumer base in the countries including India, China, South Korea, and others. Increasing expenditure on health-enhancing products in the region owing to growing per capita income and increasing awareness is expected to drive the demand for dietary supplements over the forecast period. The European region accounted for a significant revenue share in 2021 and is expected to grow at 6.9% over the forecast period. Higher consumer awareness and higher per capita disposable income in developed countries like France, Germany, and the U.K. are expected to drive the market over the forecast period.

Some of the prominent players in the Dietary Supplements Market include:

  • Bayer
  • NBTY Inc
  • Bionova Lifesciences
  • Nu Skin Enterprises
  • Carlyle Group
  • Pfizer
  • Arkopharma Laboratoires Pharmaceutiques
  • Glanbia
  • Herbalife International
  • Abbott Laboratories
  • GlaxoSmithKline
  • Nature’s Sunshine Forms
  • Amway
  • Archer Daniels Midland

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

By Type

  • Vitamins
  • Minerals
  • Fibers & Specialty Carbohydrates
  • Omega Fatty Acids
  • Botanicals
  • Proteins & Amino Acids
  • Others

By Form

  • Capsules
  • Tablets
  • Gummies
  • Soft gels
  • Liquids
  • Powders
  • Others

By Application

  • General Health
  • Energy & Weight Management
  • Gastrointestinal Health
  • Diabetes
  • Bone & Joint Health
  • Immunity
  • Cardiac Health
  • Anti-cancer
  • Others

By End User

  • Geriatric
  • Adults
  • Children
  • Infants

By Type

  • OTC
  • Prescribed

By Distribution Channel 

  • Offline
    • Hypermarkets/Supermarkets
    • Pharmacies
    • Specialty Stores
    • Practioner
    • Others
  • Online

By Function

  • Additional supplements
  • Medicinal supplements
  • Sports nutrition

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Points Covered in Dietary Supplements Market Study:

  • Growth of Dietary Supplements in 2022
  • Market Estimates and Forecasts (2017-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  • Chapter 1. Introduction

    1.1. Research Objective
    1.2. Scope of the Study
    1.3. Definition

    Chapter 2. Research Methodology

    2.1. Research Approach
    2.2. Data Sources
    2.3. Assumptions& Limitations

    Chapter 3. Executive Summary

    3.1. Market Snapshot

    Chapter 4. Dietary Supplements Market Variables and Scope

    4.1. Introduction
    4.2. Market Classification and Scope

    Chapter 5. COVID 19 Impact on Dietary Supplements Market

    5.1. Covid-19: Dietary Supplements Industry Impact
    5.2. Dietary Supplements Business Impact Assessment: Covid-19
    5.2.1. Services Challenges/Disruption
    5.2.2. Market Trends and Dietary Supplements Opportunities in the COVID-19 Landscape for Major Markets
    5.3. Strategic Measures against Covid-19
    5.3.1. Government Support and Initiative to Combat Covid-19
    5.3.2. Proposal for Dietary Supplements Market Players to deal with Covid-19 Pandemic Scenario

    Chapter 6. Dietary Supplements Market Dynamics Analysis and Trends

    6.1. Market Dynamics
    6.1.1. Market Drivers
    6.1.1.1. Rising health concerns and the changing lifestyles
    6.1.1.2. Growth in the number of sports complexes and gymnasiums
    6.1.2. Market Restraints
    6.1.2.1. Rising demand for organic food
    6.1.3. Market Opportunities
    6.1.3.1. Emerging applications

    Chapter 7. Global Dietary Supplements Market: Competitive Landscape

    7.1.1. Company Market Share/Positioning Analysis
    7.1.1.1. Dietary Supplements Market Revenue by Market Players (2017 - 2020)
    7.1.1.2. Dietary Supplements Market Revenue Market Share by Market Players (2017 - 2020)
    7.1.2. Key Organic/Inorganic Strategies Adopted by Players
    7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
    7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
    7.1.3. Market Players Landscape
    7.1.3.1. List of Suppliers
    7.1.3.2. List of End-users

    Chapter 8. Global Dietary Supplements Market, By Type

    8.1. Dietary Supplements Market, by Type, 2017-2030
    8.1.1. Vitamins
    8.1.1.1. Market Revenue and Forecast (2017-2030)
    8.1.2. Minerals
    8.1.2.1. Market Revenue and Forecast (2017-2030)
    8.1.3. Fibers & Specialty Carbohydrates
    8.1.3.1. Market Revenue and Forecast (2017-2030)
    8.1.4. Omega Fatty Acids Botanicals
    8.1.4.1. Market Revenue and Forecast (2017-2030)
    8.1.5. Proteins & Amino Acids
    8.1.5.1. Market Revenue and Forecast (2017-2030)
    8.1.6. Others
    8.1.6.1. Market Revenue and Forecast (2017-2030)

    Chapter 9. Global Dietary Supplements Market, By Applications

    9.1. Dietary Supplements Market, by Applications, 2017-2030
    9.1.1. General Health
    9.1.1.1. Market Revenue and Forecast (2017-2030)
    9.1.2. Energy & Weight Management
    9.1.2.1. Market Revenue and Forecast (2017-2030)
    9.1.3. Gastrointestinal Health
    9.1.3.1. Market Revenue and Forecast (2017-2030)
    9.1.4. Diabetes
    9.1.4.1. Market Revenue and Forecast (2017-2030)
    9.1.5. Bone & Joint Health
    9.1.5.1. Market Revenue and Forecast (2017-2030)
    9.1.6. Immunity
    9.1.6.1. Market Revenue and Forecast (2017-2030)
    9.1.7. Cardiac Health
    9.1.7.1. Market Revenue and Forecast (2017-2030)
    9.1.8. Anti-cancer
    9.1.8.1. Market Revenue and Forecast (2017-2030)
    9.1.9. Others
    9.1.9.1. Market Revenue and Forecast (2017-2030)

    Chapter 10. Global Dietary Supplements Market, By Form

    10.1. Dietary Supplements Market, by Form, 2017-2030
    10.1.1. Capsules
    10.1.1.1. Market Revenue and Forecast (2017-2030)
    10.1.2. Tablets
    10.1.2.1. Market Revenue and Forecast (2017-2030)
    10.1.3. Gummies
    10.1.3.1. Market Revenue and Forecast (2017-2030)
    10.1.4. Soft gels
    10.1.4.1. Market Revenue and Forecast (2017-2030)
    10.1.5. Liquids
    10.1.5.1. Market Revenue and Forecast (2017-2030)
    10.1.6. Powders
    10.1.6.1. Market Revenue and Forecast (2017-2030)
    10.1.7. Others
    10.1.7.1. Market Revenue and Forecast (2017-2030)

    Chapter 11. Global Dietary Supplements Market, By End user

    11.1. Dietary Supplements Market, by End user, 2017-2030
    11.1.1. Geriatric
    11.1.1.1. Market Revenue and Forecast (2017-2030)
    11.1.2. Adults
    11.1.2.1. Market Revenue and Forecast (2017-2030)
    11.1.3. Children
    11.1.3.1. Market Revenue and Forecast (2017-2030)
    11.1.4. Infants
    11.1.4.1. Market Revenue and Forecast (2017-2030)

    Chapter 12. Global Dietary Supplements Market, Regional Estimates and Trend Forecast

    12.1. North America
    12.1.1. Market Revenue Forecast by Type(2017-2030)
    12.1.2. Market Revenue Forecast by Application (2017-2030)
    12.1.3. Market Revenue Forecast by Form (2017-2030)
    12.1.4. Market Revenue Forecast by End user (2017-2030)
    12.1.5. U.S
    12.1.5.1. Market Revenue Forecast (2017-2030)
    12.1.6. Canada
    12.1.6.1. Market Revenue Forecast (2017-2030)
    12.2. Europe
    12.2.1. Market Revenue Forecast by Type (2017-2030)
    12.2.2. Market Revenue Forecast by Application (2017-2030)
    12.2.3. Market Revenue Forecast by Form (2017-2030)
    12.2.4. Market Revenue Forecast by End user (2017-2030)
    12.2.5. UK
    12.2.5.1. Market Revenue Forecast (2017-2030)
    12.2.6. Germany
    12.2.6.1. Market Revenue Forecast (2017-2030)
    12.2.7. France
    12.2.7.1. Market Revenue Forecast (2017-2030)
    12.2.8. Rest of EU
    12.2.8.1. Market Revenue Forecast (2017-2030)
    12.3. Asia Pacific (APAC)
    12.3.1. Market Revenue Forecast by Type (2017-2030)
    12.3.2. Market Revenue Forecast by Application (2017-2030)
    12.3.3. Market Revenue Forecast by Form (2017-2030)
    12.3.4. Market Revenue Forecast by End user (2017-2030)
    12.3.5. China
    12.3.5.1. Market Revenue Forecast (2017-2030)
    12.3.6. India
    12.3.6.1. Market Revenue Forecast (2017-2030)
    12.3.7. Japan
    12.3.7.1. Market Revenue Forecast (2017-2030)
    12.3.8. Rest of APAC
    12.3.8.1. Market Revenue Forecast (2017-2030)
    12.4. LATAM
    12.4.1. Market Revenue Forecast by Type (2017-2030)
    12.4.2. Market Revenue Forecast by Application (2017-2030)
    12.4.3. Market Revenue Forecast by Form (2017-2030)
    12.4.4. Market Revenue Forecast by End user (2017-2030)
    12.4.5. Brazil
    12.4.5.1. Market Revenue Forecast (2017-2030)
    12.4.6. Rest of LATAM
    12.4.6.1. Market Revenue Forecast (2017-2030)
    12.5. Middle East and Africa (MEA)
    12.5.1. Market Revenue Forecast by Type (2017-2030)
    12.5.2. Market Revenue Forecast by Application (2017-2030)
    12.5.3. Market Revenue Forecast by Form (2017-2030)
    12.5.4. Market Revenue Forecast by End user (2017-2030)
    12.5.5. GCC
    12.5.5.1. Market Revenue Forecast (2017-2030)
    12.5.6. North Africa
    12.5.6.1. Market Revenue Forecast (2017-2030)
    12.5.7. South Africa
    12.5.7.1. Market Revenue Forecast (2017-2030)
    12.5.8. Rest of MEA
    12.5.8.1. Market Revenue Forecast (2017-2030)

    Chapter 13. Company Profiles

    13.1. Bayer
    13.1.1. Company Overview, Business Information, Regional Presence
    13.1.2. Product Portfolio Analysis
    13.1.2.1. Product Details, Specification, Application
    13.1.3. Revenue, Price, and Gross Margin (2017-2020)
    13.1.4. Recent Developments and Strategies
    13.2. NBTY Inc
    13.2.1. Company Overview, Business Information, Regional Presence
    13.2.2. Product Portfolio Analysis
    13.2.2.1. Product Details, Specification, Application
    13.2.3. Revenue, Price, and Gross Margin (2017-2020)
    13.2.4. Recent Developments and Strategies
    13.3. Bionova Lifesciences
    13.3.1. Company Overview, Business Information, Regional Presence
    13.3.2. Product Portfolio Analysis
    13.3.2.1. Product Details, Specification, Application
    13.3.3. Revenue, Price, and Gross Margin (2017-2020)
    13.3.4. Recent Developments and Strategies
    13.4. Nu Skin Enterprises
    13.4.1. Company Overview, Business Information, Regional Presence
    13.4.2. Product Portfolio Analysis
    13.4.2.1. Product Details, Specification, Application
    13.4.3. Revenue, Price, and Gross Margin (2017-2020)
    13.4.4. Recent Developments and Strategies
    13.5. Carlyle Group
    13.5.1. Company Overview, Business Information, Regional Presence
    13.5.2. Product Portfolio Analysis
    13.5.2.1. Product Details, Specification, Application
    13.5.3. Revenue, Price, and Gross Margin (2017-2020)
    13.5.4. Recent Developments and Strategies
    13.6. Pfizer
    13.6.1. Company Overview, Business Information, Regional Presence
    13.6.2. Product Portfolio Analysis
    13.6.2.1. Product Details, Specification, Application
    13.6.3. Revenue, Price, and Gross Margin (2017-2020)
    13.6.4. Recent Developments and Strategies
    13.7. Arkopharma Laboratoires Pharmaceutiques
    13.7.1. Company Overview, Business Information, Regional Presence
    13.7.2. Product Portfolio Analysis
    13.7.2.1. Product Details, Specification, Application
    13.7.3. Revenue, Price, and Gross Margin (2017-2020)
    13.7.4. Recent Developments and Strategies
    13.8. Glanbia
    13.8.1. Company Overview, Business Information, Regional Presence
    13.8.2. Product Portfolio Analysis
    13.8.2.1. Product Details, Specification, Application
    13.8.3. Revenue, Price, and Gross Margin (2017-2020)
    13.8.4. Recent Developments and Strategies
    13.9. Herbalife International
    13.9.1. Company Overview, Business Information, Regional Presence
    13.9.2. Product Portfolio Analysis
    13.9.2.1. Product Details, Specification, Application
    13.9.3. Revenue, Price, and Gross Margin (2017-2020)
    13.9.4. Recent Developments and Strategies
    13.10. Abbott Laboratories
    13.10.1. Company Overview, Business Information, Regional Presence
    13.10.2. Product Portfolio Analysis
    13.10.2.1. Product Details, Specification, Application
    13.10.3. Revenue, Price, and Gross Margin (2017-2020)
    13.10.4. Recent Developments and Strategies
    13.11. GlaxoSmithKline
    13.11.1. Company Overview, Business Information, Regional Presence
    13.11.2. Product Portfolio Analysis
    13.11.2.1. Product Details, Specification, Application
    13.11.3. Revenue, Price, and Gross Margin (2017-2020)
    13.11.4. Recent Developments and Strategies
    13.12. Nature’s Sunshine Forms
    13.12.1. Company Overview, Business Information, Regional Presence
    13.12.2. Product Portfolio Analysis
    13.12.2.1. Product Details, Specification, Application
    13.12.3. Revenue, Price, and Gross Margin (2017-2020)
    13.12.4. Recent Developments and Strategies
    13.13. Amway
    13.13.1. Company Overview, Business Information, Regional Presence
    13.13.2. Product Portfolio Analysis
    13.13.2.1. Product Details, Specification, Application
    13.13.3. Revenue, Price, and Gross Margin (2017-2020)
    13.13.4. Recent Developments and Strategies
    13.14. Archer Daniels Midland
    13.14.1. Company Overview, Business Information, Regional Presence
    13.14.2. Product Portfolio Analysis
    13.14.2.1. Product Details, Specification, Application
    13.14.3. Revenue, Price, and Gross Margin (2017-2020)
    13.14.4. Recent Developments and Strategies

    Chapter 14. Appendix

    14.1. About Us
    14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers